|
|
Volumn 26, Issue 9, 2008, Pages 962-963
|
|
Western biotechs ponder follow-on possibilities
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL FACTOR;
GENERIC DRUG;
HUMAN GROWTH HORMONE;
INS 19;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
UNCLASSIFIED DRUG;
BIOEQUIVALENCE;
BIOTECHNOLOGY;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG MARKETING;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
LAW;
NOTE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
UNITED STATES;
BIOTECHNOLOGY;
CANADA;
DRUG INDUSTRY;
EUROPE;
FILGRASTIM;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 51349118103
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0908-962 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
